SABS
SAB Biotherapeutics Inc

1,656
Loading...
Loading...
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. The company was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
63

Frequently Asked Questions

What is Market Cap of SAB Biotherapeutics Inc?
What is the 52-week high for SAB Biotherapeutics Inc?
What is the 52-week low for SAB Biotherapeutics Inc?
What is SAB Biotherapeutics Inc stock price today?
What was SAB Biotherapeutics Inc stock price yesterday?
What is the PE ratio of SAB Biotherapeutics Inc?
What is the Price-to-Book ratio of SAB Biotherapeutics Inc?
What is the 50-day moving average of SAB Biotherapeutics Inc?
How many employess does SAB Biotherapeutics Inc has?

Latest SABS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.